Our world-leading Nano Electronic X-ray (NEX) Technology forms the core of a common platform for all our products, delivering quality digital imaging through proprietary high-voltage X-ray tubes and high-voltage generators.
Micro-X develops and commercializes innovative products for global health and security markets. We create revolutionary X-ray imaging to better lives.
With a vertically integrated design and production facility in Adelaide, Australia and a strong technical and commercial team based in Seattle, USA, we are focused on delivering exceptional innovative products to underpin our commercial growth.
Please contact research analysts listed below to receive their latest research on Micro-X.
Scott Power, Morgans Financial
1800 777 946
Micro-X is listed on the Australian Securities Exchange (ASX), trading as MX1. Computershare maintains our ASX shareholder registry. For all enquiries relating to your shareholding, contact:
The Registrar
Computershare Investor Services Pty Ltd
GPO Box 2975
Australia
Aus: 1300 555 159
Intl: +61 (0)3 9415 4062
Shareholders can access information on their holding online with Computershare.
Overseas investors can purchase ASX-listed shares, including Micro-X, through a number of local brokers. Please enquire with your broker if they enable you to trade ASX shares, or contact us to help identify a broker at:
.jpg)
In a world-first initiative, Micro-X’s Head CT scanner will play a central role in a groundbreaking clinical trial set to reshape stroke care across Australia’s most remote regions.
Micro-X has partnered with FUJIFILM to create a world-first curved detector for the Head CT for stroke diagnosis. Hear from Mechanical Engineer Mia Maric on how the curved detector will play a part in transforming stroke care.
Micro-X has signed a major U.S. supply agreement, giving over 700 hospitals direct access to its Rover Plus mobile X-ray system. This milestone marks a breakthrough in U.S. market entry and validates Rover Plus as a trusted solution for acute care imaging.
